메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기

Company

COMPANY

OVERVIEW

  • Established

    JAN 29, 2010

     

  • President & CEO

    Jaeseung Yoon

     

  • Capital

    6.5 billion KRW

     

  • Employees

    79 people

     

Biosimilar pharmaceutical production and sales business
Biopharmaceutical contract manufacturing organization business
Biopharmaceutical contract development organization technology transfer business
New biologics development business

The platform patented technology,
a stable and fast growing biopharmaceutical company

  • A global biologics specialized company with core technologies/ personnel/ equipment

    We have a biopharmaceutical development platform technology/production technology, research personnel/production personnel with abundant experience, and GMP production facilities.
    We are growing into a global biopharmaceutical specialized company.

  • Global biopharmaceutical product development

    We are developing Biosimilar products, a high-growth business, biopharmaceutical development technology, a stable and sustainable business technology transfer service products.

  • Highly successful sales strategy

    We are building a sales network early through joint clinical trials and licensing with domestic and foreign pharmaceutical companies including emerging markets.